Sort
17,288 grants matching “multiple sclerosis”
Nogo Receptors as Therapeutic Targets in a Model of Multiple Sclerosis
$0Benjamin Matthew Segal · Veterans Health Administration · I01 · FY2013 · VA
Immunoregulation of Myelin Specific T Lymphocytes
$0Arthur A. Vandenbark · Portland Va Medical Center · I01 · FY2013 · VA
Evaluation of a Spasticity Management Program for People with Multiple Sclerosis
$0Lucinda L Hugos · Portland Va Medical Center · I01 · FY2019 · VA
Study and Treatment of Visual Dysfunction and Motor Fatigue in Multiple Sclerosis
$0Alessandro Serra · Louis Stokes Cleveland Va Medical Center · IK2 · FY2016 · VA
Principles of Therapy in Cerebellar Disease: Explorations in Ion Channel Mutants
$0John S Stahl · Louis Stokes Cleveland Va Medical Center · I01 · FY2011 · VA
BLR&D Research Career Scientist Award for Dr. Barbel Rohrer
$0Baerbel Rohrer · Ralph H Johnson Va Medical Center · IK6 · FY2022 · VA
Modulating microglial phenotype to prevent SCI-induced central neuropathic pain
$0Mousumi Ghosh · Miami Va Health Care System · I01 · FY2021 · VA
Molecular aspects of antigen presentation in multiple sclerosis
$0Dana-Farber Cancer Institute · P01 · FY2001 · AI
Multiple Antigenic Peptides to Alter the Course of Autoimmune Disease
$0David J. Hinrichs · Portland Va Medical Center · I01 · FY2012 · VA
Determining the compartmental role of B cell subsets during CNS autoimmunity
$0Olaf Stuve · Va North Texas Health Care System · I01 · FY2014 · VA
Nogo Receptors as Therapeutic Targets in a Model of Multiple Sclerosis
$0Benjamin Matthew Segal · Veterans Health Administration · I01 · FY2016 · VA
EVALUATE EFFICACY OF AVONEX &SECONDARY MULTIPLE SCLEROSIS
$0Ohio State University · M01 · FY2000 · RR
Modulation of Th17 plasticity by intestinal paleobiomic fauna
$0David E Elliott · Iowa City Va Medical Center · I01 · FY2015 · VA
PHASE 2 STUDY OF HU23F2G IN ACUTE EXACERBATIONS OF MULTIPLE SCLEROSIS
$0Ohio State University · M01 · FY2000 · RR
Analysis of MS T cells using combinatorial libraries and MHC/peptide tetramers
$0Dana-Farber Cancer Institute · P01 · FY2001 · AI
TREATMENT OF FATIGUE IN MULTIPLE SCLEROSIS WITH PROVIGIL (MODAFINIL)
$0Ohio State University · M01 · FY2000 · RR
Role of CD44 in experimental Multiple Sclerosis
$0Mitzi Nagarkatti · Veterans Health Administration · I01 · FY2013 · VA
Study and Treatment of Visual Dysfunction and Motor Fatigue in Multiple Sclerosis
$0Alessandro Serra · Louis Stokes Cleveland Va Medical Center · IK2 · FY2018 · VA
Cyclical muscle vibration in MS to improve walking
$0Stephen Michael Selkirk · Louis Stokes Cleveland Va Medical Center · I21 · FY2018 · VA
TCR recognition of MHC class II peptide compexes in multiple sclerosis
$0Dana-Farber Cancer Institute · P01 · FY2001 · AI
Sphingosine-1-phosphate system as a therapeutic target for amyotrophic lateral sclerosis
$0Alpaslan Dedeoglu · Va Boston Health Care System · I01 · FY2022 · VA
Analysis of a Type I Interferon Responsive Microglia Subset in Traumatic Brain Injury
$0Christine Linda Hsieh · Veterans Affairs Med Ctr San Francisco · I01 · FY2022 · VA
TWO DOSES OF BETASERON IN PATIENTS WITH SECONDARY PROGR
$0Ohio State University · M01 · FY2000 · RR
Corticospinal control of spinal reflex plasticity
$0Jonathan Rickel Wolpaw · Stratton Veterans Admin Medical Center · I01 · FY2022 · VA
Neuroprotection and Myelin Repair Mechanisms in Multiple Sclerosis
$0Inderjit Singh · Ralph H Johnson Va Medical Center · I01 · FY2011 · VA